- $12 BnWorld market, 2023
- $22.3 BnProjected, 2033
- 6.4%Growth a year (CAGR)
- 21Active clinical trials worldwide
Largest countries
Market size in 2023 · growth a year to 2033
-
1
US
$5 Bn
4.4% a year · 42% of the world -
2
China
$965 Mn
7.9% a year · 8% of the world -
3
Canada
$960 Mn
6.4% a year · 8% of the world -
4
Japan
$746 Mn
6.9% a year · 6.2% of the world -
5
Germany
$439 Mn
4.6% a year · 3.7% of the world -
6
France
$330 Mn
5.4% a year · 2.8% of the world -
7
UK
$312 Mn
4.4% a year · 2.6% of the world -
8
Brazil
$300 Mn
7.4% a year · 2.5% of the world -
9
Italy
$288 Mn
5.9% a year · 2.4% of the world -
10
Ecuador
$240 Mn
7% a year · 2% of the world
Most clinical trials
Active trials by country (ClinicalTrials.gov)
See every trial on ClinicalTrials.gov (opens in a new tab)
MalaysiaBone & Joint Health Supplements by country and region
Spain
India
Saudi Arabia
Mexico
Australia
South Africa
UAE
Egypt
Philippines
Hong Kong
Singapore
Thailand
Kenya
New Zealand
Russia"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.
Latest research 4,667 papers since 2021
- Venetoclax Elicits Nephrotoxicity Through TLR4/MyD88-Mediated Innate Immune Activation and IFN-γ Signaling. Journal of applied toxicology : JAT, 2026
- Protecting-group-free access to a glucosamine phenethyl carbamate as a selective ethanol organogelator. Soft matter, 2026
- Electromotive drug administration accelerates intravesical tissue uptake of gemcitabine and docetaxel into porcine bladders: an ex vivo proof-of-concept study. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2026
- Fungal residues dominate microbial contributions to soil carbon sequestration during 170 years of vegetation succession. Environmental research, 2026
- Lysosomal Glycosaminoglycan Catabolism Regulates Microglial Cell State in the Developing CNS. bioRxiv : the preprint server for biology, 2026
Compare Bone & Joint Health Supplements side by side
Key companies in Bone & Joint Health Supplements
Arazo Nutrition
Archer Daniels Midland
Bayer AG
BASF SE
Nature's Sunshine Products
Pfizer
Procter & Gamble
Reckitt Benckiser
Vita Life Sciences Ltd
Quick answers
How big is the Bone & Joint Health Supplements market?
The world Bone & Joint Health Supplements market was worth about $12 Bn in 2023 and is projected to reach $22.3 Bn by 2033, growing 6.4% a year (CAGR).
Which country has the largest Bone & Joint Health Supplements market?
The US is the largest of the 24 countries we cover, at $5 Bn in 2023. India grows fastest, at 9.4% a year.
How many clinical trials are running in Bone & Joint Health Supplements?
ClinicalTrials.gov lists 21 active trials worldwide (recruiting, about to start or running), most of them in the US, as of 10 Nov 2026.
How much research is published on Bone & Joint Health Supplements?
PubMed lists about 4,667 papers on the topic since 2021.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.